Cisplatin plus etoposide with and without ifosfamide in extensive small-cell lung cancer: a Hoosier Oncology Group study.
PJ Loehrer Sr, R Ansari, R Gonin, F Monaco… - Journal of clinical …, 1995 - ascopubs.org
PURPOSE To determine whether the addition of ifosfamide to cisplatin plus etoposide
improves the response rate, time to disease progression, or overall survival in previously …
improves the response rate, time to disease progression, or overall survival in previously …
Phase II study of ifosfamide, carboplatin, and oral etoposide chemotherapy for extensive-disease small-cell lung cancer: an Eastern Cooperative Oncology Group pilot …
PURPOSE A phase II study of ifosfamide, carboplatin, and prolonged oral administration of
etoposide (ICE) in patients with untreated extensive-disease (ED) small-cell lung cancer …
etoposide (ICE) in patients with untreated extensive-disease (ED) small-cell lung cancer …
A phase III comparison of etoposide/cisplatin with or without added ifosfamide in small-cell lung cancer
H Miyamoto, T Nakabayashi, H Isobe, H Akita… - Oncology, 1992 - karger.com
A total of 92 patients with small-cell lung cancer (SCLC) were randomized to receive
cisplatin (80 mg/m2, day l)/etoposide (100 mg/m2, days 1, 3, 5)(PE) or cisplatin (80 mg/m2 …
cisplatin (80 mg/m2, day l)/etoposide (100 mg/m2, days 1, 3, 5)(PE) or cisplatin (80 mg/m2 …
Cisplatin/etoposide versus ifosfamide/etoposide combination chemotherapy in small-cell lung cancer: a multicenter German randomized trial.
M Wolf, K Havemann, R Holle, C Gropp… - Journal of Clinical …, 1987 - ascopubs.org
A total of 144 patients with small-cell lung cancer (SCLC) were randomized to receive
cisplatin/etoposide (PE) or ifosfamide/etoposide (IE) combination chemotherapy. PE …
cisplatin/etoposide (PE) or ifosfamide/etoposide (IE) combination chemotherapy. PE …
Carboplatin, etoposide, and ifosfamide as intensive chemotherapy for small-cell lung cancer.
IE Smith, TJ Perren, SA Ashley, J Woodiwiss… - Journal of Clinical …, 1990 - ascopubs.org
Thirty-two previously untreated, fit patients with small-cell lung carcinoma (SCLC) were
treated with an intensive combination chemotherapy regimen, with the aim of prolonging …
treated with an intensive combination chemotherapy regimen, with the aim of prolonging …
Cisplatin, ifosfamide, oral etoposide, and concurrent accelerated hyperfractionated thoracic radiation for patients with limited small-cell lung carcinoma: results of …
B Glisson, C Scott, R Komaki, B Movsas… - Journal of clinical …, 2000 - ascopubs.org
PURPOSE: The combination of cisplatin, ifosfamide, and oral etoposide (PIEo) given
concurrently with accelerated hyperfractionated thoracic radiation was studied in patients …
concurrently with accelerated hyperfractionated thoracic radiation was studied in patients …
Randomized study of cyclophosphamide, doxorubicin, and vincristine versus etoposide and cisplatin versus alternation of these two regimens in extensive small-cell …
BJ Roth, DH Johnson, LH Einhorn… - Journal of clinical …, 1992 - ascopubs.org
PURPOSE The trial was undertaken to determine (1) the relative efficacy/toxicity of two
commonly used combination chemotherapy regimens in patients with extensive small-cell …
commonly used combination chemotherapy regimens in patients with extensive small-cell …
Cisplatin, etoposide, and paclitaxel in the treatment of patients with extensive small-cell lung carcinoma
BS Glisson, JM Kurie, R Perez-Soler, NJ Fox… - Journal of clinical …, 1999 - ascopubs.org
PURPOSE: The combination of cisplatin, etoposide, and paclitaxel was studied in patients
with extensive small-cell lung cancer in a phase I component followed by a phase II trial to …
with extensive small-cell lung cancer in a phase I component followed by a phase II trial to …
Sequencing and schedule effects of cisplatin plus etoposide in small-cell lung cancer: results of a North Central Cancer Treatment Group randomized clinical trial.
AW Maksymiuk, JR Jett, JD Earle, JQ Su… - Journal of clinical …, 1994 - ascopubs.org
PURPOSE The combination of etoposide (E) and cisplatin (P) is an accepted standard
therapy for small-cell lung cancer (SCLC); however, the optimal sequencing and …
therapy for small-cell lung cancer (SCLC); however, the optimal sequencing and …
Combination chemotherapy with or without thoracic radiotherapy in limited-stage small-cell lung cancer: a randomized trial of the Southeastern Cancer Study Group.
DH Johnson, D Bass, LH Einhorn… - Journal of clinical …, 1993 - ascopubs.org
PURPOSE The primary objective of this randomized prospective study was to compare the
survival of limited-stage small-cell lung cancer (SCLC) patients treated with chemotherapy …
survival of limited-stage small-cell lung cancer (SCLC) patients treated with chemotherapy …